Protein Design Labs Adds $25M To ESP Pharma Acquisition Price

Protein Design Labs Inc. raised its purchase price for ESP Pharma Inc. by $25
million in cash after ESP acquired exclusive North America rights to Retavase
from Johnson & Johnson unit Centocor Inc.